Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Wei Yu"'
Autor:
Laddawan Potprommanee, Yi-Hsiu Juan, Shui-Tein Chen, Lalida Shank, Haou-Tzong Ma, Wei-Yu Liao, Chong-Jen Yu
Publikováno v:
Journal of Thoracic Oncology. 10:102-109
IntroductionEffective biomarkers for early diagnosis of lung cancer are needed. A recent study demonstrated that urinary GM2-activator protein (GM2AP) level was increased in lung cancer patients. This study aims to validate the potential application
Autor:
Wei-Yu Liao, Yuh Min Chen, Gee-Chen Chang, James Chih-Hsin Yang, Yu-Kai Cheng, Chong-Jen Yu, Jin-Yuan Shih
Publikováno v:
Journal of Thoracic Oncology. (6):973-981
IntroductionElevated DNA-repair capacity has been related to chemoresistance of platinum doublet chemotherapy in non–small-cell lung cancer (NSCLC). We evaluated whether single nucleotide polymorphisms of DN- repair genes excision repair cross-comp
Bcl-2-Like Protein 11 Deletion Polymorphism Predicts Survival in Advanced Non–Small-Cell Lung Cancer
Autor:
Wei-Hsun Hsu, Chong-Jen Yu, Yu-Lin Lin, Chao-Chi Ho, Kuan-Yu Chen, Yeun-Chung Chang, Jin-Yuan Shih, Chia-Chi Lin, Wei-Yu Laio, Jih-Hsiang Lee, Pan-Chyr Yang, James Chih-Hsin Yang, Hsuan-Yu Chen
Publikováno v:
Journal of Thoracic Oncology. (9):1385-1392
Introduction Germline Bcl-2-like protein 11 (BIM) deletion polymorphism in Asian is a poor predictive factor for treatment outcomes to tyrosine kinase inhibitors (TKIs) in malignancies. We explored the impact of BIM deletion polymorphism on treatment